Polymorphisms of the angiotensinogen gene, the endothelial nitric oxide synthase gene, and the interleukin-1beta gene promoter in women with idiopathic recurrent miscarriage.
暂无分享,去创建一个
R. Zeillinger | C. Schneeberger | L. Hefler | C. Tempfer | J. Huber | H. Koelbl | F. Nagele | G. Unfried | M. Bashford | Michael T. Bashford
[1] G. Barkai,et al. Karyotype of the abortus in recurrent miscarriage , 2001, Fertility and sterility.
[2] C. Schneeberger,et al. Interleukin 1 receptor antagonist polymorphism in women with idiopathic recurrent miscarriage. , 2001, Fertility and sterility.
[3] H. Okamura,et al. The missense Glu298Asp variant of the endothelial nitric oxide synthase gene is strongly associated with placental abruption , 2001, Human Genetics.
[4] Jm Roberts,et al. Pathogenesis and genetics of pre-eclampsia , 2001, The Lancet.
[5] S. Duffy,et al. The Carriage of Pro‐Inflammatory Cytokine Gene Polymorphisms in Recurrent Pregnancy Loss , 2001, American journal of reproductive immunology.
[6] C. Glueck,et al. Genetic Hypofibrinolysis in Complicated Pregnancies , 2001, Obstetrics and gynecology.
[7] K. Bremme,et al. Primary habitual abortions are associated with high frequency of factor V Leiden mutation. , 2000, Fertility and sterility.
[8] E. Taioli,et al. Mutations in coagulation factors in women with unexplained late fetal loss. , 2000, The New England journal of medicine.
[9] S. Padmanabhan,et al. Genetics of hypertension: from experimental models to clinical applications , 2000, Journal of Human Hypertension.
[10] T. Yoshimura. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with severe preeclampsia. , 2000 .
[11] J. Walker,et al. Evidence of a T(H) 1 type response associated with recurrent miscarriage. , 2000, Fertility and sterility.
[12] H. Blom,et al. Polymorphisms in biotransformation enzymes and the risk for recurrent early pregnancy loss. , 2000, Molecular human reproduction.
[13] J. Moss,et al. Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[14] A. Gregg,et al. Genetic Control of Fertility and Embryonic Waste in the Mouse: A Role for Angiotensinogen1 , 2000, Biology of reproduction.
[15] L. Lind. Endothelium-dependent Vasodilation in Hypertension: A Review , 2000, Blood pressure.
[16] K. Nakao,et al. T-786-->C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. , 1999, Circulation.
[17] KazuwaNakao,et al. T−786→C Mutation in the 5′-Flanking Region of the Endothelial Nitric Oxide Synthase Gene Is Associated With Coronary Spasm , 1999 .
[18] V. Park,et al. Hypercoagulable state mutation analysis in white patients with early first-trimester recurrent pregnancy loss. , 1999, Fertility and sterility.
[19] I. Aifantis,et al. Inhibition of nitric oxide production rescues LPS-induced fetal abortion in mice. , 1999, Nitric oxide : biology and chemistry.
[20] M. Prins,et al. Increased Risk for Fetal Loss in Carriers of the Factor V Leiden Mutation , 1999, Annals of Internal Medicine.
[21] F. Lyall,et al. Human trophoblast invasion and spiral artery transformation: the role of nitric oxide. , 1999, The American journal of pathology.
[22] W. März,et al. Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease. , 1999, American heart journal.
[23] H Yasue,et al. Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction. , 1998, Journal of the American College of Cardiology.
[24] Santtila,et al. Presence of the IL‐1RA Allele 2 (IL1RN*2) is Associated with Enhanced IL‐1β Production In Vitro , 1998, Scandinavian journal of immunology.
[25] T. Borg,et al. The effects of angiotensin II and specific angiotensin receptor blockers on embryonic cardiac development and looping patterns. , 1997, Developmental biology.
[26] T. Ishimitsu,et al. Angiotensin-converting enzyme gene polymorphism and cardiovascular endocrine system in coronary angiography patients. , 1997, Japanese heart journal.
[27] J. Lalouel,et al. Haplotypes of angiotensinogen in essential hypertension. , 1997, American journal of human genetics.
[28] C. Rotimi,et al. Hypertension, serum angiotensinogen, and molecular variants of the angiotensinogen gene among Nigerians. , 1997, Circulation.
[29] M. Shaarawy,et al. Enhanced expression of cytokines may play a fundamental role in the mechanisms of immunologically mediated recurrent spontaneous abortion , 1997, Acta obstetricia et gynecologica Scandinavica.
[30] P. Corvol,et al. Early expression of all the components of the renin-angiotensin-system in human development. , 1996, The American journal of pathology.
[31] D. Anderson,et al. T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. , 1995, JAMA.
[32] J. Crusius,et al. Allelic polymorphism in IL‐1β and IL‐1 receptor antagonist (IL‐1Ra) genes in inflammatory bowel disease , 1995, Clinical and experimental immunology.
[33] E. Haddad,et al. Early embryo loss is associated with local production of nitric oxide by decidual mononuclear cells , 1995, The Journal of experimental medicine.
[34] H. S. Kim,et al. Genetic control of blood pressure and the angiotensinogen locus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[35] D. Clayton,et al. Linkage of the angiotensinogen gene to essential hypertension. , 1994, The New England journal of medicine.
[36] Ian G. Charles,et al. Mapping of the genes encoding human inducible and endothelial nitric oxide synthase (NOS2 and NOS3) to the pericentric region of chromosome 17 and to chromosome 7, respectively. , 1994, Genomics.
[37] T. Mosmann,et al. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? , 1993, Immunology today.
[38] J. Lalouel,et al. A molecular variant of angiotensinogen associated with preeclampsia , 1993, Nature Genetics.
[39] D. Hartl,et al. Principles of population genetics , 1981 .
[40] P. Froguel,et al. Genetic determinants of type 2 diabetes. , 2001, Recent progress in hormone research.
[41] W. O'Brien,et al. Endothelial-derived nitric oxide and angiotensinogen: blood pressure and metabolism during mouse pregnancy. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.
[42] T. Unger,et al. The renin-angiotensin system and its receptors. , 1999, Journal of cardiovascular pharmacology.
[43] P. López-Jaramillo,et al. The L-arginine: nitric oxide pathway. , 1993, Current opinion in nephrology and hypertension.